Intrinsic fluorescence accurately identifies coronary plaques with superficial foam cells and high content of proteoglycans and smooth muscle cells  by Angheloiu, George O. et al.
42A ABSTRACTS - Angiography & Interventional Cardiology JACC March 19,2003 
between RCA and control group (p=O.lO). 
Conclusions: Coronary sinus blood temperature measurement is increased compared 
to that of right atrium in patients with significant lesions in LCA. This technique may prove 
useful in identifying patients with enhanced inflammatory involvement and additional 
studies are required for evaluating the clinical significance of coronary sinus thermogra- 
phy in risk stratification and prognosis. 
1102-182 Comparison of Culprit Lesions Showing Negative 
Remodeling Between Acute Coronary Syndrome and 
Stable Angina Pectoris 
Shoichi Ehara, Yoshiki Kobayashi, Daijyu Fukuda, Yasuhiro Nakamura, Shinichi 
Shimodozono, Haiime Yamashita, Kenei Shimada, Minoru Yoshivama. Kazuhide 
Takeuchi, JunichiYoshikawa, Makiko &da, Osaka City University, Osaka, Japan 
Background: Previous intravascular ultrasound (IVUS) studies have shown that positive 
remodeling (PR) is associated with acute coronary syndromes (ACS), whereas negative 
remodeling (NR) is more common in stable angina pectoris (SAP). However, NR could 
be found in 30.50% of patients with ACS. The purpose of this study is to elucidate 
whether some differences are present at the culprit lesion showing NR in patients with 
ACS and SAP. Methods Preinterventional IVUS images of 136 patients (99 ACS. 37 
SAP) were identified. Remodeling ratio (RR) was defined as the ratio of external elastic 
membrane area at the culprit lesion to at the proximal reference. NR was defined as 
RRc0.95. Results In ACS group, NR was observed in 39 patients (39%), while in SAP 
group NR was found in 23 patients (62%). In lesions showing NR, calcified plaques were 
more frequent in SAP (ACS: 15%, SAP: 50%), but in ACS no calcification plaques were 
more common (ACS: 51%. SAP: 25%) (p<O.O5). Moreover, patients showing NR in ACS 
were significantly younger than in SAP (p< 0.05). Conclusion : The differences in plaque 
morphology of NR between ACS and SAP may reflect different progression mechanisms 
of NR in ACS, eventually this may lead to acute coronary event. 
1102-183 In-\livo Characterization of Plaque Morphology by 
Optical Coherence Tomography Predicts Coronary 
Artery Remodeling 
Briain D. Mac Neill, Harry C. Lowe, Eugene Pomeranstev, Denise DeJoseph, Hiroshi 
Yabushita, Guiflermo J. Tearney, Brett E. Bouma, Ik-Kyung Jang, Massachusetts 
General Hospital, Boston, MA, Wellman Laboratory of Photomedicine, Boston, MA 
Background: The pathophysiology of remodeling and its relationship to plaque morphol- 
ogy are poorly understood. Positive remodeling is associated with acute coronary syn- 
dromes, whereas negative remodeling more commonly presents as stable angina. 
Optical coherence tomography (OCT) is a high resolution imaging technique capable of 
in-viva plaque characterization. 
Hypothesis: Plaque morphology, characterized in -viva by OCT. predicts coronary 
remodeling. 
Methods: lntracoronary OCT imaging was performed with a 3.2 Fr OCT catheter. Intra- 
vascular ultrasound (IVUS) was performed with a 40Hz Atlantis” catheter. At each site, 
the external elastic membrane (EEM) area was measured using IVUS and the plaque 
was characterized using OCT. The remodeling ratio (RR) was calculated as the ratio of 
the EEM at the culprit lesion to the EEM at the proximal reference. Positive remodeling 
was defined as an RR > 1.05, negative remodeling as an RR< 0.95; and absence of 
remodeling as an RR between 0.95 and 1.05. 
Results: A total of 62 lesions were imaged in 50 patients. The results are shown in the 
table. Positive remodeling was more common in lipid rich plaque and negative remodel- 
ing in fibrous plaque. Mixed plaque was associated with both positive and negative 
remodeling. 
Conclusion: This is the first in-viva demonstration of the relationship between plaque 
morphology and arterial remodeling response. Lipid rich plaque resulted in positive 
remodeling, supporting the role of remodeling in plaque vulnerability. 
Lipid Rich Plaque MixedPlaque Fibrous Plaque p Value 
Number 27 15 40 
Positive 16 9 0 0.002 
Remodeling 
Negative 1 3 3 
Remodeling 
No 10 3 37 
Remodeling 
Remodeling Index 1.17 f 0.16 0.69 * 0.14 0.77 f 0.12 0.001 
1102-184 Detection of Thin-Capped Fibroatheromas in Human 
Aorta Tissue With Near Infrared Spectroscopy Through 
Blood 
Barbara Marshik , Huwei Tan, Jing Tang, Anna Lindquist, Andres Zuluaga, InfraReDx. 
Incorporated, Cambridge, MA 
Background: A method is needed to identify thin-capped fibroatheroma likely to cause 
acute coronary events in humans. We tested the ability of near infrared (NIR) spectros- 
copy to characterize tissue through blood without vessel occlusion. 
Methods: NIR spectra of human aorlic tissue were acquired through whole blood at 
36°C from 400 - 2500 nm using a l/2 inch fiber optic probe. Probe-to-specimen depths 
were varied simulating in viva parameters up to 1.5mm. Lipid rich aortic plaques were 
separated into three groups: disrupted. thin-capped, and thick-capped with average cap 
thicknesses of 231+791,237*102p, and 629*14Op respectively. Partial least squares - 
discriminant analysis was used to create models using disrupted plaques with classifica- 
tion as the prediction mode. 
Results The first model discriminated other plaque compositions from both thin-capped 
and thick-capped plaques (see Class Separation in Table) with excellent results. A sec- 
ond model was built that optimized the discrimination between the thin-capped and thick- 
capped plaques through variable depths. The model was also used to discriminate other 
tissue types with good results (see Cap Separation in Table). Better results are antici- 
pated with a smaller probe illumination area. 
Conclusion: NIR spectroscopy can identify thin-capped plaques through blood with high 
sensitivity and specificity supporting the development of a NIR catheter to identify thin- 
capped fibroatheromas through blood in tiw in coronary arteries. 
MODEL Thin- Thick- Fibrotic Calcific Normal 
Capped Capped (Specificity) (Specificity) (Specificit 
(Sensitivit n=20 n=35 n=33 Y) 
Y) n=41 
n=16 
Class 
Separation 
CaP 
Separation 
93% 70% SENS 91% 65% 96% 
66% 72%’ 
SPEC 
89% 96% 99% 
’ Disrupted versus Fibrotic plaques used in training set’ Disrupted versus Thick- 
capped lipid plaques used in training set. 
1102-185 Circadian Variation of Plaque Rupture in Patients With 
Acute Myocardial Infarction 
Atsushi Tanaka, Takahiko Kawarabayashi, Toshihiko Sane, Hiroki Oe, Yoshiharu 
Nishibori, Masashi Namba, Yukio Nishida, Daiju Fukuda, Kenei Shimada, Junichi 
Yoshikawa, Baba Memorial Hospital, Sakai, Japan, Osaka City University, Osaka, Japan 
Background: Studies have reported a circadian variation in the onset of acute myocardial 
infarction (AMI). Pathological studies have revealed that plaque rupture is one of the 
major causes of AMI, but none of these has looked specifically at the circadian variation 
of plaque rupture. The aim of this study was to use intravascular ultrasound (IVUS) to 
investigate the circadian variation of plaque rupture in AMI. 
Methods: This study comprised 174 consecutive patients with AMI who underwent pre- 
intervention IVUS. All patients were assigned to either a rupture group or a non-rupture 
group according to the pre-intervention IVUS. 
Results: In the 61 (47%) patients in the rupture group, the frequency of the onset of AMI 
increases significantly in the period from 6 AM to 12 noon compared with all the other 
periods (respectively, p<O.O5). The clinical features of AMI in the rupture group were 
characterized as occurring significantly more at rest (67% vs. 31%, pcO.Ol), and after 
significantly less pre-infarction angina (22% vs. 57%, p<O.Ol) compared with the non- 
rupture group. A different circadian variation was identified in the non-rupture group, 
characterized as a significant nocturnal nadir (12:OO midnight to 6 AM, compared with all 
other periods, respectively, pcO.05). 
Conclusion: The circadian variation of AMI is the result of a morning increase in inci- 
dence of plaque rupture. Our results may be of benefit for understanding and preventing 
the onset of some classes of AMI. 
1102-186 Intrinsic Fluorescence Accurately Identifies Coronary 
Plaques With Superficial Foam Cells and High Content 
of Proteoglycans and Smooth Muscle Cells 
Georqe 0. Anqheloiw Jonathan T. Arendt, Markus G. Mueller. Irene Georgakoudi, 
Abigail S. Haka, Jason T. Motz, Barry D. Kuban, Jonathan Myles, Eugene A. Podrez, 
Michael S. Feld, John R. Kramer, The Cleveland Clinic Foundation, Cleveland, OH, 
Massachusetts Institute of Technology, Cambridge, MA 
Background Plaques with abundant superficial proteoglycans (PG) and smooth muscle 
cells (SMC) are prone to erosion and thrombus development. Superficial foam cells 
(SFC) are another important cause of coronary plaque instability and thrombogenicity. 
We hypothesize that areas with SFC are rich in PG and SMC, and intrinsic fluorescence 
(IF) is an accurate method for their detection. 
Methods We subjected 35 normal, and 96 intimal thickening and atheromatous coronary 
segments harvested from heart transplant and autopsy cases to measurements of reflec- 
tance and multiple excitation wavelength &) laser induced fluorescence. We used 
hematoxylin and eosin slides to quantify the area occupied by SFC on a target surface 
represented by the superficial 200pm of each specimen, on a transversal length equal to 
the diameter of the optic probe used for spectroscopic measurements (1000 pm). 
Movat’s and anti a actin staining were performed in specimens with SFC. After process- 
ing the spectroscopic data, we extracted IF spectra, fit them to a linear combination of 
collagen, necrotic core lkpoproteins and SFC spectra at X,=460 nm, and then calculated 
the SFC and collagen contribution to IF at this wavelength. The SFC spectrum has been 
obtained through computational methods and validated against spectra of Cu and 
myeloperoxidase oxidized LDL. A diagnostic algorithm, employing leave-one-out cross- 
validation and logistic regression, was built using the ratio of SFC and collagen contribu- 
tions to IF at X,=460 nm as diagnostic parameter, to separate coronary segments with 
SFC from those without. 
ResultsSFC were histologically noted in 10 intimal thickening, 12 fibrous cap atheroma- 
tous and 2 thin fibrous cap atheromatous specimens. Large accumulations of PG in- 
between and under the SFC were noted in 9 intimal thickening and 12 fibrous cap ather- 
ornatous specimens. SMC were observed in the SFC area in 6 intimal thickening and 6 
fibrous cap atheromatous specimens. The algorithm built as described diagnosed the 
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specimens with SFC with sensitlwty 83% and specificity 86%. 
Conclusion IF at&=480 nm identifies SFC in plaques with high content of PG and SMC 
and in thin fibrous cap atheromas. 
ORAL CONTRIBUTIONS 
820 Novel Approaches to Percutaneous 
Coronary Intervention With Emphasis on 
Saphenous Vein Grafts 
Monday, March 31, 2003, 2!00 p.m.-3:30 p.m. 
McCormick Place, Room S401 
2:oo p.m. 
820-l A Prospective, Randomized Trial of 
Thromboatherectomy During Intervention of 
Thrombotic Native Coronary Arteries and Saphenous 
Vein Grafts: The X-TRACT Trial 
Grsqa W. Stone, David A. Cox, Joseph D. Babb, Dean Nukta, Luc Bilodeau, Louis 
Cannon, Thomas D. Stuckey, James Hermiller, Eric Cohen, Reginald Low, Alexandra J. 
Lansky, Steven R. Bailey, Richard E. Kuntz, Cardiovascular Research FoundationlLenox 
Hill Heart and Vascular Institute, New York, NY 
Background. Peri-procedural complications are increased during PCI of SVGs and 
native coronary arleries containing thrombus. Whether outcomes may be improved by 
thrombectomy prior to intervention is unknown. 
Methods. At 75 U.S. sites, 800 consecutive pts with diseased SVGs (72%) or native cor- 
onary lesions containing thrombus (28%) were prospectively randomized to standard 
PCI vs. thromboatherectomy with the ev3 X-SIZER followed by PCI. Randomization was 
stratified by Ilb/llla use. 
Results. Baseline clinical and angiographic characteristics were well matched, excepi 
that by core lab determination X-SIZER patients were more likely to have thrombus 
present (70% vs. 58%, p<O.OOl), and had a slightly greater initial diameter stenosis (70% 
vs. 67%, p-zO.05). GP Ilb/llla inhibitors were administered in 78% of each group. Rates of 
post procedure TIMI flow, no reflow and distal emboli were similar in the 2 groups. 
Among pts not receiving upfront Ilb/lila inhibitors, ball-out Ilb/llla use was required in 
fewer patients treated with the X-SIZER (2.1% vs. 10.3%, p=O.O2). The 30.day compos- 
ite major adverse cardiac event rate (death, MI, or TVR) was similar in pts treated with X- 
SIZER vs. control (17.0% vs. 17.4% respectively, p=NS). The X-SIZER did, however, 
lower the pre-specified rate of large Ml (Q-wave Ml or peak CPK-MB >8x nl) by 41% 
(5.5% vs. 9.6%, p=O.O3). After accounting for the difference in baseline thrombus and 
lesion severity by multwariate analysis, use of the X-SIZER was an independent predlc- 
tor of freedom from large Ml (odds ratio = 0.35, p=O.O02) and death or large Ml (OR = 
0.43, p&006). 
Conclusions. Performance of thromboatherectomy with the X-SIZER prior to PCI in dis- 
eased SVGs or thrombotlc native coronary lesions does not reduce the overall 30 day 
composite rate of adverse events. X-SIZER use does, however, reduce procedural com- 
plications as evidenced by less need for bail-out GP Ilb/llla inhibitors, and enhances 30. 
day survival free from large MI. 
2:15 p.m. 
820-2 Treatment of Saphenous Vein Bypass Grafts With 
Ultrasound Thrombolysis: A Randomized Study 
Mandeeo Sinoh Uri Rosenscheim. Kalon K. Ho, Peter B. Berger, Richard Kuntz, David 
R. Holmes, Jr., Mayo Clinic, Rochester, MN 
BackgroundPercutaneous coronary interventions (PCI) I” patients with saphenous vein 
grafts (SVG) have a high frequency of distal embolization and other adverse clinical 
events, particularly if thrombus is present. Acolysis (therapeutic ultrasound) has the abil- 
ity to break up thrombus in vitro, in animal models, and in humans. Whether this is bene- 
ficial during percutaneous SVG interventions is unknown. 
ObjectiveWe performed a randomized trial of Coronary Ultrasound Thrombolysis (CUT) 
in which patients with an acute coronary syndrome undergoing PCI in a SVG were ran- 
domly assigned to receive treatment with acolysis or therapy with abciximab. The pri- 
mary end point of study was a successful procedure without complications at 30 days 
defined as a final luminal diameter stenosis <30% by quantitative angiographic analysis 
with Thrombolysis In Myocardial Infarction (TIMI) grade 3 flow and freedom from major 
adverse cardiac events (MACE- a composite of death, Q and non-Q-wave myocardial 
infarction, emergency bypass surgery, disabling stroke, and target lesion revasculariza- 
tron) at 30 days. 
Results. One hundred and eighty one patients, 92 randomized to acolysis and 89 to 
abciximab, were enrolled. The two groups were well matched for baseline and lesion 
characteristics. Angiographic procedural success was achieved in 83% of patients ran- 
domized to acolysis and 82% randomized to abciximab (p=O.O08). The cumulative inci- 
dence of MACE at 30 days was 25% I” the acolysis vs. 12% in the abciximab group 
(p=O.O38). due mainly to a greater frequency of non-Q-wave myocardial infarction 
(19.6% vs 7.9%, p=O.O3) in patients treated with acolysis. The incidence of Q-wave myo- 
cardial InfarctIon was also higher in patients treated with acolysis (5.4% vs 2.2%, p=NS). 
The primary end point was thus achieved in 53.8% of acolysis and 73.1% of abciximab 
patients (p=O.O14) 
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ConclusionsIn this randomized trial, use of therapeutic ultrasound in vein graft lesions 
in patients with acute coronary syndrome was associated with poor angiographic out- 
come and increased the incidence of acute ischemic complications. 
2:30 p.m. 
820-3 Predictors of Adverse Clinical Outcome in the 
Randomized Evaluation of Covered Stent in Saphenous 
Vein Graft (RECOVERS) Trial 
Goran Stank@& Antonio Colombo, Fabio Sgura, Flavio Airoldi, Carlo Briguori, 
Nicholaous Reifart, Patrizia Presbitero, Luigi Inglese. G. Heyndrickx, Carlo Di Mario, 
EM0 Centro Cuore Columbus, Milan, Italy. San Raffaele Hospital, Milan, Italy 
In the Randomized Evaluation of Covered Stent in Saphenous Vein Graft (RECOVERS) 
trial polytetrafluoroethylene (PTFE) covered stent was compared with stainless steel 
(SS) stent for prevention of major adverse cardiac events (MACE) for treatment of 
saphenous vein graft (SVG) lesions. The results of this trial have already been pre- 
sented. We aimed to determine clinical, angiographic and procedural predictors of 
adverse B-month clinical outcome. 
Methods and results: 292 pts ware randomized to PTFE JOSTENT (152 pts) and SS 
JOSTENT Flex (140 pts). Pts received aspirin and ticlopidine for 3 months. MACE were 
defined as death, myocardial infarction (Ml) and repeat revascularization. Cumulative 8- 
month MACE rate was 31% in PTFE group vs 19% in SS group (P=O.Ol), with Ml rate of 
14% vs 5.5% (P=O.O2). 
Multivariate analysis identified following predictors of Ml: prior stroke (coeff -2.46, 
P=O.O06), ref. vessel size (c&f. -1.52, P=O.O03), stent length (coeff. -0.11. P=O.O2), final 
min. lumen diameter (coeff 1.21, P=O.O3). Predictors of cumulative MACE were: use of 
PTFE stents (co& 0.78, P=O.O2), lesion length (coeff -0.05, PcO.02) and trend was 
found for COmDlianCs to 3-month ticlooidine theraov fceof 0.76. P=O.O9). Fioura shows 
. L .  I” 
calculated probability of MACE according to lesion length, compliance to 3 month ticlopi- 
dine therapy and use of PTFE stents. Conclusion: Use of PTFE covered stents to treat 
long SVG lesions and non-compliance to ticlopidine therapy negatively affects six-month 
clinical outcome 
” Y x4 c I 
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A Prospective Randomized Multicenter Trial Comparing 
Distal Protection During Saphenous Vein Graft 
Intervention With a Filter-Based Device Compared to 
Balloon Occlusion and Aspiration: The FIRE Trial 
Greoa W. Stone, Campbell Rogers, James Hermiller, Robert Feldman, Patrick Hall, 
Robert Haber, A. Masud, Patrick Cambier, Ronald P. Caputo, Mark Turco, Richard 
Kovach, Bruce R. Brodie. Howard Herrmann. Richard Kuntz, Steve Ramee, David A. 
Cox, Cardiovascular Research FoundationlLenox Hill Heart and Vascular Institute, New 
York, NY 
Background. Percutaneous intervention (PCI) in diseased saphenous vain grafts (SVG) 
is associated with a high peri-procedural rate of complications. Distal protection dunng 
SVG PCI using a balloon occlusion and aspiration system (the PercuSurge GuardWire) 
has been shown in a large randomized trial to reduce 30 day MACE rates by 42%. Com- 
pared to balloon occlusion systems, filter-based distal protection devices may be simpler 
to use, and allow antegrade perfusion during the procedure, reducing ischemia time and 
facilitating intervention in pts with poor LV function. The absolute clinical efficacy of distal 
filters as an adjunct to PCI rn diseased SVGs has not been proven. however, nor has 
their relative efficacy compared to balloon occlusion/aspiration systems. 
Methods. We therefore performed a large, multicenter non-inferiority trial of PCI in dis- 
eased SVGs in which 650 consecutive pts at 65 U.S. and Canadian centers were ran- 
domized I:1 to intervention with distal protection using the BSC/EPI FillerWire EX vs. the 
PercuSurge GuardWire. The FilterWire consists of a microporous polyurethane net 
attached to a self-expanding nitinol ring anchored distally to a 0.014’ guidewire over 
which PCI is performed. Crossing profile is 3.9F. Randomization was stratified by use of 
Ilb/llla inhibitors, the administration of which was left to the discretion of the operators. 
The primary endpoint was the composite rate of death, Ml (CPK-MB z-3.x nl), CABG or 
target lesion revascularrzation at 30 days. 
Results. The last patient was enrolled in August, 2002. Pooling the pts, the mean age 
was 69+ 10 years, 21% were female, 31% had prior MI. 39% had diabetes, 82% hyper- 
tension, 86% hyperlipidemia, and 12% renal insufficiency. Baseline LVEF was 49% -+ 
12%. The mean graft age was 11 _+8 years. 
Conclusions. FIRE is the first completed large-scale randomized trial comparing filter- 
